Literature DB >> 24924553

Predictors of cancer-specific mortality after disease recurrence in patients with squamous cell carcinoma of the penis.

Malte Rieken1, Rosa S Djajadiningrat2, Luis A Kluth3, Ricardo L Favaretto4, Evanguelos Xylinas5, Gustavo C Guimaraes4, Fernando A Soares6, Matthew Kent7, Daniel D Sjoberg7, Simon Horenblas2, Shahrokh F Shariat8.   

Abstract

Disease recurrence occurs frequently after surgical treatment for squamous cell carcinoma of the penis (SCCp). We sought to determine prognostic factors that influence cancer-specific mortality (CSM) after disease recurrence in patients with SCCp. We performed a retrospective analysis of 314 patients who experienced disease recurrence after surgical treatment for SCCp between 1949 and 2012. Competing risk regression analysis addressed factors associated with CSM after SCCp recurrence. Median time from surgery to disease recurrence was 10.5 mo (interquartile range [IQR]: 5.9-21.3). Of the recurrences, 165 (53%), 118 (38%), and 31 (9.9%) were local, regional, or distant, respectively. Within a median follow-up of 4.5 yr (IQR: 2.0-6.5), 108 patients died of SCCp and 41 patients died of causes other than SCCp. Shorter time to disease recurrence was found to be significantly associated with a higher risk of CSM (p=0.0006). Lymph node metastasis at the time of initial treatment (subdistribution hazard ratio [SHR]: 1.96; 95% confidence interval [CI] 1.23- 3.11; p=0.005) and regional recurrence (SHR: 4.14; 95% CI, 2.16-7.93; p<0.0001) or distant recurrence (SHR: 5.75; 95% CI, 2.59-12.73; p<0.0001) were associated with increased risk of CSM after disease recurrence. Inclusion of time to recurrence into risk stratification may help patient counseling and treatment planning.
Copyright © 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer-specific survival; Outcomes; Penile cancer; Prognostic factors; Recurrence

Mesh:

Year:  2014        PMID: 24924553     DOI: 10.1016/j.eururo.2014.05.032

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  2 in total

Review 1.  Surveillance strategies in the management of penile cancer.

Authors:  Simpa S Salami; Jeffrey S Montgomery
Journal:  Transl Androl Urol       Date:  2017-10

2.  Correlation Between the Evolution of Somatic Alterations During Lymphatic Metastasis and Clinical Outcome in Penile Squamous Cell Carcinoma.

Authors:  Jian Cao; Chun-He Yang; Wei-Qing Han; Yu Xie; Zhi-Zhong Liu; Shu-Suan Jiang
Journal:  Front Oncol       Date:  2021-06-02       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.